Thomas P Miller

  • 19295 Citations
  • 58 h-Index
1978 …2016

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
1979

CHEMOTHERAPY OF LOCALISED HISTIOCYTIC LYMPHOMA

Miller, T. P. & Jones, S. E., Feb 17 1979, In : The Lancet. 313, 8112, p. 358-360 3 p.

Research output: Contribution to journalArticle

57 Scopus citations

Improved survival for patients with advanced non-small-cell carcinoma of the lung

Miller, T. P., Dec 1 1979, In : Arizona Medicine. 36, 12, p. 893-897 5 p.

Research output: Contribution to journalArticle

1980
27 Scopus citations

Phase II trial of vindesine in breast cancer, lymphoma and other tumors: Future directions

Miller, T. P., Jones, S. E., Chester, A. B. & Dorr, R. T., Sep 1980, In : Cancer Treatment Reviews. 7, SUPPL. 1, p. 81-86 6 p.

Research output: Contribution to journalArticle

9 Scopus citations

Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors

Miller, T. P., Jones, S. E. & Chester, A., Dec 1 1980, In : Cancer Treatment Reports. 64, 8-9, p. 1001-1003 3 p.

Research output: Contribution to journalArticle

8 Scopus citations
1982

Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): A Southwest Oncology Group study

Miller, T. P., Weick, J. K., Grozea, P. N. & Carlin, D. A., Jan 1 1982, In : Cancer Treatment Reports. 66, 3, p. 553-556 4 p.

Research output: Contribution to journalArticle

11 Scopus citations

Mistaken clinical and pathologic diagnoses of Hodgkin's disease: A Southwest Oncology Group Study

Miller, T. P., Byrne, G. E. & Jones, S. J., Jan 1 1982, In : Cancer Treatment Reports. 66, 4, p. 645-651 7 p.

Research output: Contribution to journalArticle

29 Scopus citations
1 Scopus citations
1983
2 Scopus citations

Initial chemotherapy for clinically localized lymphomas of unfavorable histology

Miller, T. P. & Jones, S. E., 1983, In : Blood. 62, 2, p. 413-418 6 p.

Research output: Contribution to journalArticle

Open Access
150 Scopus citations

Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine

Garewal, H. S., Brooks, R. J., Jones, S. E. & Miller, T. P., Jan 1 1983, In : Journal of Clinical Oncology. 1, 12, p. 772-775 4 p.

Research output: Contribution to journalArticle

33 Scopus citations

Treatment of small cell lung cancer with VP-16, vincristine, doxorubicin (Adriamycin), cyclophosphamide (EVAC), and high-dose chest radiotherapy

Goodman, G. E., Miller, T. P., Manning, M. M., Davis, S. L. & McMahon, L. J., Jan 1 1983, In : Unknown Journal. 1, 8, p. 483-488 6 p.

Research output: Contribution to journalArticle

22 Scopus citations
1984

Evaluation of anticancer drug schedule dependency using an in vitro human tumor clonogenic assay

Ludwig, R., Alberts, D. S., Miller, T. P. & Salmon, S. E., Apr 1 1984, In : Cancer Chemotherapy And Pharmacology. 12, 3, p. 135-141 7 p.

Research output: Contribution to journalArticle

29 Scopus citations

Phase II trial of bisantrene in patients with intermediate and high grade diffuse non-Hodgkin's lymphomas

Miller, T. P., Jones, S. E., Alberts, D. S. & Mackel, C., Mar 1 1984, In : Investigational New Drugs. 2, 1, p. 75-77 3 p.

Research output: Contribution to journalArticle

2 Scopus citations

Pseudonodular T cell lymphoblastic lymphoma

Schwarte, J. E., Grogan, T. M., Hicks, M. J., Weinrach, R. S. & Miller, T. P., Nov 1984, In : The American journal of medicine. 77, 5, p. 947-949 3 p.

Research output: Contribution to journalArticle

5 Scopus citations
1985

Chemohormonal therapy for advanced breast cancer with tamoxifen, adriamycin, and cyclophosphamide (TAC)

Ahmann, F. R., Jones, S. E., Moon, T. E., Hammond, N., Miller, T. P. & Durie, B. G. M., Aug 15 1985, In : Cancer. 56, 4, p. 730-737 8 p.

Research output: Contribution to journalArticle

4 Scopus citations

Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: A southwest oncology group study

Jones, S. E., Grozea, P. N., Miller, T. P., Van Slyck, E. J., Balcerzak, S. P., Costanzi, J. J., Morrison, F. S., Eyre, H. J., Fabian, C. J. & Dabich, L., Jan 1 1985, In : Journal of Clinical Oncology. 3, 10, p. 1318-1324 7 p.

Research output: Contribution to journalArticle

54 Scopus citations

Immunotopographic assessment of lymphoid and plasma cell malignancies in the bone marrow

Kronland, R., Grogan, T., Spier, C., Wirt, D., Rangel, C., Richter, L., Durie, B., Greenberg, B., Miller, T. & Jones, S., Dec 1985, In : Human pathology. 16, 12, p. 1247-1254 8 p.

Research output: Contribution to journalArticle

12 Scopus citations

Morphological subclassification of follicular lymphoma: Variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies

Metter, G. E., Nathwani, B. N., Burke, J. S., Winberg, C. D., Mann, R. B., Barcos, M., Kjeldsberg, C. R., Whitcomb, C. C., Dixon, D. O. & Miller, T. P., Jan 1 1985, In : Journal of Clinical Oncology. 3, 1, p. 25-38 14 p.

Research output: Contribution to journalArticle

99 Scopus citations

Peripheral T-cell lymphoma: Aggressive disease with heterogeneous immunotypes

Grogan, T. M., Fielder, K., Rangel, C., Jolley, C. J., Wirt, D. P., Hicks, M. J., Miller, T. P., Brooks, R., Greenberg, B. & Jones, S., Jan 1 1985, In : American journal of clinical pathology. 83, 3, p. 279-288 10 p.

Research output: Contribution to journalArticle

119 Scopus citations
3 Scopus citations

Phase II trial of bisantrene in non-small cell lung cancer

Miller, T. P., Ahmann, F. R., Mackel, C., Greenberg, B. R. & Alberts, D. S., Dec 1 1985, In : Investigational New Drugs. 3, 4, p. 393-395 3 p.

Research output: Contribution to journalArticle

1986

A phase II study of bisantrene in malignant lymphomas - A southwest oncology group study

Miller, T. P., Cowan, J. D., Neilan, B. A. & Jones, S. E., Jan 1 1986, In : Cancer Chemotherapy And Pharmacology. 16, 1, p. 67-69 3 p.

Research output: Contribution to journalArticle

3 Scopus citations

Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: The Southwest Oncology Group experience

Dixon, D. O., Neilan, B., Jones, S. E., Lipschitz, D. A., Miller, T. P., Grozea, P. N. & Wilson, H. E., Jan 1 1986, In : Journal of Clinical Oncology. 4, 3, p. 295-305 11 p.

Research output: Contribution to journalArticle

314 Scopus citations

Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A southwest oncology group study

Miller, T. P., Chen, T. T., Coltman, C. A., O'Bryan, R. M., Vance, R. B., Weiss, G. B., Fletcher, W. S., Stephens, R. L. & Livingston, R. B., Jan 1 1986, In : Journal of Clinical Oncology. 4, 4, p. 502-508 7 p.

Research output: Contribution to journalArticle

40 Scopus citations

Extensive non-small cell lung cancer treated with mitomycin, cisplatin, and vindesine (MiPE): A Southwest Oncology Group Study

Miller, T. P., Vance, R. B., Ahmann, F. R. & Rodney, S. R., Jan 1 1986, In : Cancer Treatment Reports. 70, 9, p. 1101-1104 4 p.

Research output: Contribution to journalArticle

22 Scopus citations

Immunologic complexity of lymphoblastic lymphoma

Grogan, T., Spier, C., Wirt, D. P., Hicks, M. J., Paquin, M., Hutter, J., Miller, T., Rangel, C., Richter, L. & Jones, S., Jul 16 1986, In : Diagnostic immunology. 4, 2, p. 81-88 8 p.

Research output: Contribution to journalArticle

20 Scopus citations

Immunotyping malignant lymphomas. A boon to diagnosis.

Grogan, T. M., Spier, C. M. & Miller, T. P., Sep 1 1986, In : Cleveland Clinic Quarterly. 53, 3, p. 315-317 3 p.

Research output: Contribution to journalArticle

Leukocyte concentrations in discrimination of benign from malignant lung lesions

Thomson, S. P., Kessler, J. F. & Miller, T. P., Jun 1986, In : The American journal of medicine. 80, 6, p. 1035-1040 6 p.

Research output: Contribution to journalArticle

12 Scopus citations

Phase II trial of esorubicin (4′ deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma

Braich, T. A., Salmon, S. E., Robertone, A., Alberts, D. S., Jones, S. E., Miller, T. P. & Garewal, H. S., Sep 1 1986, In : Investigational New Drugs. 4, 3, p. 269-274 6 p.

Research output: Contribution to journalArticle

6 Scopus citations

What should be the morphologic criteria for the subdivision of follicular lymphomas?

Nathwani, B. N., Metter, G. E., Miller, T. P., Burke, J. S., Mann, R. B., Barcos, M., Kjeldsberg, C. R., Dixon, D. O., Winberg, C. D. & Whitcomb, C. C., Jan 1 1986, In : Blood. 68, 4, p. 837-845 9 p.

Research output: Contribution to journalArticle

Open Access
57 Scopus citations
1987

Mitotic counts in follicular lymphomas

Ellison, D. J., Nathwani, B. N., Metter, G. E., Turner, R. R., Burke, J. S., Miller, T. P., Mann, R. B., Barcos, M., Kjeldsberg, C. R., Winberg, C. D. & Whitcomb, C. C., May 1987, In : Human pathology. 18, 5, p. 502-505 4 p.

Research output: Contribution to journalArticle

17 Scopus citations

Post-transplantation T cell lymphoblastic lymphoma

Lippman, S. M., Grogan, T. M., Carry, P., Ogden, D. A. & Miller, T. P., Apr 1987, In : The American journal of medicine. 82, 4, p. 814-816 3 p.

Research output: Contribution to journalArticle

45 Scopus citations

Radiation therapy salvage of Hodgkin's disease following chemotherapy failure

Fox, K. A., Lippman, S. M., Cassady, J. R., Heusinkveld, R. S. & Miller, T. P., Jan 1 1987, In : Journal of Clinical Oncology. 5, 1, p. 38-45 8 p.

Research output: Contribution to journalArticle

53 Scopus citations

Salvage therapy of advanced hodgkin's disease. Critical appraisal of curative potential

Buzaid, A. C., Lippman, S. M. & Miller, T. P., Sep 1987, In : The American journal of medicine. 83, 3, p. 523-532 10 p.

Research output: Contribution to journalArticle

47 Scopus citations

Southwest oncology group clinical trials for intermediate-and high-grade non-hodgkin's lymphomas

Fisher, R. I., Miller, T. P., Dana, B. W., Jones, S. E., Dahlberg, S. & Coltman, C. A., Apr 1 1987, In : Seminars in Hematology. 24, 2 SUPPL. 1, p. 21-25 5 p.

Research output: Contribution to journalArticle

51 Scopus citations
1988

HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma

Miller, T. P., Lippman, S. M., Spier, C. M., Slymen, D. J. & Grogan, T. M., Jan 1 1988, In : Journal of Clinical Investigation. 82, 1, p. 370-372 3 p.

Research output: Contribution to journalArticle

Open Access
73 Scopus citations

Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67

Grogan, T. M., Lippman, S. M., Spier, C. M., Slymen, D. J., Rybski, J. A., Rangel, C. S., Richter, L. C. & Miller, T. P., 1988, In : Blood. 71, 4, p. 1157-1160 4 p.

Research output: Contribution to journalArticle

Open Access
185 Scopus citations

Lennert's lymphoma: A clinicopathologic study with emphasis on phenotype and its relationship to survival

Spier, C. M., Lippman, S. M., Miller, T. P. & Grogan, T. M., Feb 1 1988, In : Cancer. 61, 3, p. 517-524 8 p.

Research output: Contribution to journalArticle

23 Scopus citations

Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.

Miller, T. P., Dana, B. W., Weick, J. K., Jones, S. E., Coltman, C. A., Dahlberg, S. & Fisher, R. I., Apr 1988, In : Seminars in hematology. 25, 2 Suppl 2, p. 17-22 6 p.

Research output: Contribution to journalArticle

36 Scopus citations

The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma

Spier, C. M., Grogan, T. M., Lippman, S. M., Slymen, D. J., Rybski, J. A. & Miller, T. P., Jan 1 1988, In : American Journal of Pathology. 133, 1, p. 118-126 9 p.

Research output: Contribution to journalArticle

38 Scopus citations

The prognostic significance of the immunotype in diffuse large-cell lymphoma: A comparative study of the T-cell and B-cell phenotype

Lippman, S. M., Miller, T. P., Spier, C. M., Slymen, D. J. & Grogan, T. M., 1988, In : Blood. 72, 2, p. 436-441 6 p.

Research output: Contribution to journalArticle

Open Access
114 Scopus citations
1989

Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer - A Southwest Oncology Group study

Collins, C., Higano, C. S., Livingston, R. B., Griffin, B. R., Keppen, M. D. & Miller, T. P., Aug 1 1989, In : Cancer Chemotherapy And Pharmacology. 24, 2, p. 128-132 5 p.

Research output: Contribution to journalArticle

1 Scopus citations

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: Detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy

Dalton, W. S., Grogan, T. M., Meltzer, P. S., Scheper, R. J., Durie, B. G. M., Taylor, C. W., Miller, T. P. & Salmon, S. E., Jan 1 1989, In : Journal of Clinical Oncology. 7, 4, p. 415-424 10 p.

Research output: Contribution to journalArticle

513 Scopus citations
97 Scopus citations

Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by p-glycoprotein staining

Salmon, S. E., Grogan, T. M., Miller, T., Scheper, R. & Dalton, W. S., May 3 1989, In : Journal of the National Cancer Institute. 81, 9, p. 696-701 6 p.

Research output: Contribution to journalArticle

179 Scopus citations
1990

Comparison of lymphangiography and computed tomography scanning in evaluating abdominal disease in stages III and IV Hodgkin's disease: A southwest oncology group study

Mansfield, C. M., Fabian, C., Jones, S., Van Slyck, E. J., Grozea, P., Morrison, F., Miller, T. P., Seibert, C. & Ayyangar, K., Dec 1 1990, In : Cancer. 66, 11, p. 2295-2299 5 p.

Research output: Contribution to journalArticle

35 Scopus citations

Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma

Slymen, D. J., Miller, T. P., Lippman, S. M., Spier, C. M., Kerrigan, D. P., Rybski, J. A., Rangel, C. S., Richter, L. C. & Grogan, T. M., Jan 1 1990, In : Journal of Clinical Oncology. 8, 6, p. 986-993 8 p.

Research output: Contribution to journalArticle

47 Scopus citations